Evidence map›Paper›PMID 35521828›Full record

ReviewBiochemical Society transactions2022

Protein-protein and protein-lipid interactions of pore-forming BCL-2 family proteins in apoptosis initiation.

Giridhar Sekar, Adedolapo Ojoawo, Tudor Moldoveanu

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Membrane Pore Formation by Peptides Studied by Fluorescence Techniques.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Apoptotic mitochondrial poration by a growing list of pore-forming BCL-2 family proteins.BioEssays : news and reviews in molecular, cellular and developmental biology · 2023
    Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Giridhar SekarDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, U.S.A.
Adedolapo OjoawoDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, U.S.A.
Tudor MoldoveanuDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, U.S.A.

Funding

Elucidating the structural basis of mitochondrial outer membrane permeabilization in apoptosisR01GM129470 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI MOLDOVEANU, TUDOR · 2020 to 2024
$1.7M
NIGMS NIH HHS R01 GM129470
6 · The paper itself

Abstract

Apoptosis is a common cell death program that is important in human health and disease. Signaling in apoptosis is largely driven through protein-protein interactions. The BCL-2 family proteins function in protein-protein interactions as key regulators of mitochondrial poration, the process that initiates apoptosis through the release of cytochrome c, which activates the apoptotic caspase cascade leading to cellular demolition. The BCL-2 pore-forming proteins BAK and BAX are the key executors of mitochondrial poration. We review the state of knowledge of protein-protein and protein-lipid interactions governing the apoptotic function of BAK and BAX, as determined through X-ray crystallography and NMR spectroscopy studies. BAK and BAX are dormant, globular α-helical proteins that participate in protein-protein interactions with other pro-death BCL-2 family proteins, transforming them into active, partially unfolded proteins that dimerize and associate with and permeabilize mitochondrial membranes. We compare the protein-protein interactions observed in high-resolution structures with those derived in silico by AlphaFold, making predictions based on combining experimental and in silico approaches to delineate the structural basis for novel protein-protein interaction complexes of BCL-2 family proteins.

Indexed as

bcl-2 Homologous Antagonist-Killer ProteinProto-Oncogene Proteins c-bcl-2Apoptosisbcl-2-Associated X ProteinHumansLipidsbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinLipidsProto-Oncogene Proteins c-bcl-2alphafoldapoptosis initiationcrystallographymitochondrial porationpore-forming BCL-2 proteinsprotein–protein interactions

Identifiers

PMID35521828
PMCPMC9310348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.